EN DE

Dr LANGLOIS Benoît

Fiche personne

coordonnées

UMR CNRS 7369 MEDyC
Campus Moulin de la Housse
BP 1039
51687 REIMS Cedex

03 26 91 38 57

benoit.langlois@univ-reims.fr

Territoire

Champagne-Ardenne

Statut

Chercheur

affiliation

UMR CNRS 7369 MEDyC - Matrice Extracellulaire et Dynamique Cellulaire MEDyC (MEDyC)

équipes/plateformes

Equipe UMR 7369 MEDyC - Equipe "Matrice extracellulaire, Cancer et Cibles thérapeutiques"

Recherche

Expertises :
- Recherche:Biologie Cellulaire
- Recherche:Biologie Moléculaire
- Recherche:Biochimie

Projets

Exploration de la contribution stromale de LRP1 à l'angiogenèse tumorale des cancers du sein

2023 - Porteur du projet : Dr LANGLOIS Benoît

Publications

LRP-1-dependent control of calpain expression and activity: A new mechanism regulating thyroid carcinoma cell adhesion.

Langlois B, Martin J, Schneider C, Hachet C, Terryn C, Rioult D, Martiny L, Théret L, Salesse S, Dedieu S

Front Oncol. 2022 08 16;12:981927

Contribution of the Low-Density Lipoprotein Receptor Family to Breast Cancer Progression.

Campion O, Al Khalifa T, Langlois B, Thevenard-Devy J, Salesse S, Savary K, Schneider C, Etique N, Dedieu S, Devy J

Front Oncol. 2020 ;10:882

Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer.

Le CC, Bennasroune A, Langlois B, Salesse S, Boulagnon-Rombi C, Morjani H, Dedieu S, Appert-Collin A

Front Oncol. 2020 ;10:527

Periostin Limits Tumor Response to VEGFA Inhibition.

Keklikoglou I, Kadioglu E, Bissinger S, Langlois B, Bellotti A, Orend G, Ries CH, De Palma M

Cell Rep. 2018 Mar 6;22(10):2530-2540

Identification of LRP-1 as an endocytosis and recycling receptor for β1-integrin in thyroid cancer cells.

Theret L, Jeanne A, Langlois B, Hachet C, David M, Khrestchatisky M, Devy J, Hervé E, Almagro S, Dedieu S

Oncotarget. 2017 Oct 3;8(45):78614-78632

Vimentin knockout results in increased expression of sub-endothelial basement membrane components and carotid stiffness in mice.

Langlois B, Belozertseva E, Parlakian A, Bourhim M, Gao-Li J, Blanc J, Tian L, Coletti D, Labat C, Ramdame-Cherif Z, Challande P, Regnault V, Lacolley P, Zhenlin L

Sci Rep. 2017 Sep;7(1):11628

Tenascin-C Orchestrates Glioblastoma Angiogenesis by Modulation of Pro- and Anti-angiogenic Signaling.

Rupp T, Langlois B, Koczorowska MM, Radwanska A, Sun Z, Hussenet T, Lefebvre O, Murdamoothoo D, Arnold C, Klein A, Biniossek ML, Hyenne V, Naudin E, Velazquez-Quesada I, Schilling O, Van Obberghen-Schilling E, Orend G

Cell Rep. 2016 Dec;17(10):2607-2619

AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients.

Langlois B, Saupe F, Rupp T, Arnold C, van der Heyden M, Orend G, Hussenet T

Oncotarget. 2014 Nov 15;5(21):10529-45.

Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model.

Saupe F, Schwenzer A, Jia Y, Gasser I, Spenle C, Langlois B, Kammerer M, Lefebvre O, Hlushchuk R, Rupp T, Marko M, van der Heyden M, Cremel G, Arnold C, Klein A, Simon-Assmann P, Djonov V, Neuville-Mechine A, Esposito I, Slotta-Huspenina J, Janssen KP, de Wever O, Christofori G, Hussenet T, Orend G

Cell Rep. 2013 Oct 31;5(2):482-92

De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.

Rath G, Schneider C, Langlois B, Sartelet H, Morjani H, Btaouri HE, Dedieu S, Martiny L

Int J Biochem Cell Biol. 2009 May;41(5):1165-72

LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells.

Dedieu S, Langlois B

Cell Adh Migr. 2008 Apr;2(2):77-80.